• Explore /
  • Poster
  • / Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013).

Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013).

Abstract Poster

Authors

null

Yasuhide Yamada

National Cancer Center Hospital, Tokyo, Japan

Yasuhide Yamada , Narikazu Boku , Junki Mizusawa , Satoru Iwasa , Shigenori Kadowaki , Norisuke Nakayama , Mizutomo Azuma , Takeshi Sakamoto , Kohei Shitara , Tatsuya Okuno , Keisho Chin , Akira Nozaki , Masaki Nakamura , Hiroki Hara , Hiroshi Katayama , Haruhiko Fukuda , Takaki Yoshikawa , Takeshi Sano , Mitsuru Sasako , Masanori Terashima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

UMIN000007652

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4009)

DOI

10.1200/JCO.2018.36.15_suppl.4009

Abstract #

4009

Poster Bd #

198

Abstract Disclosures

Similar Posters

First Author: Feng Wang

First Author: Min-Hee Ryu

First Author: Yoon-Koo Kang

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Real-world outcomes of patients with advanced gastric cancer treated with FOLFIRI.

Real-world outcomes of patients with advanced gastric cancer treated with FOLFIRI.

First Author: Ali Fawaz